FUNCTIONAL LETHALITY Trademark

Trademark Overview

On Friday, October 16, 2020, a trademark application was filed for FUNCTIONAL LETHALITY with the United States Patent and Trademark Office. The USPTO has given the FUNCTIONAL LETHALITY trademark a serial number of 90258907. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 23, 2021. This trademark is owned by Inzen Therapeutics, Inc.. The FUNCTIONAL LETHALITY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
functional lethality

General Information

Serial Number90258907
Word MarkFUNCTIONAL LETHALITY
Filing DateFriday, October 16, 2020
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, March 23, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
Goods and ServicesScientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInzen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, March 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2021NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2021NON-FINAL ACTION WRITTEN
Wednesday, March 17, 2021ASSIGNED TO EXAMINER
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 20, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

lethality functional diseases pharmaceutical research biological nature molecules development cellular others signal